Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing

PURPOSE: Gallbladder sarcomatoid carcinoma is a rare cancer with no clinical standard treatment. With the rapid development of next generation sequencing, it has been able to provide reasonable treatment options for patients based on genetic variations. However, most cancer drugs are not approval fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Feng, Feiling, Cheng, Qingbao, Yang, Liang, Zhang, Dadong, Ji, Shunlong, Zhang, Qiangzu, Lin, Yihui, Li, Fugen, Xiong, Lei, Liu, Chen, Jiang, Xiaoqing
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354913/
https://ncbi.nlm.nih.gov/pubmed/28029662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14146
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars